COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-UpBehnood Bikdeli, Gregory Y.H. Lip, Mahesh V. Madhavan et al.|Journal of the American College of Cardiology|2020Cited by 2.9k
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.Sweta Chekuri, Anand Kumar, Susan R. Kahn et al.|Bristol Research (University of Bristol)|2021Cited by 589
Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysisFaizan Khan, Marc Rodger, Alvi Rahman et al.|BMJ|2019Cited by 312
Using an age-dependent D-dimer cut-off value increases the number of older patients in whom deep vein thrombosis can be safely excludedRenée A. Douma, Marc Righini, Minkang Tan et al.|Haematologica|2012Cited by 130
Surgical Stress Promotes the Development of Cancer Metastases by a Coagulation-Dependent Mechanism Involving Natural Killer Cells in a Murine ModelRashmi Seth, Rebecca C. Auer, Lee‐Hwa Tai et al.|Annals of Surgery|2012Cited by 123